Should All Elderly Patients With Newly Diagnosed Multiple Myeloma Receive Monoclonal Antibodies?
November 17th 2020
In light of the recent approvals of combination anti-myeloma regimens containing monoclonal antibodies, as well as the robust pipeline of novel targeted agents likely to be approved in the next year, there is much optimism in the field of multiple myeloma.